Tekturna (aliskiren) / PDL, Novartis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

16 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
ARID-HF, NCT00773084: Aliskiren and Renin Inhibition in Diastolic Heart Failure

Withdrawn
N/A
0
US
Aliskiren plus spironolactone vs. Lisinopril plus spironolactone, Tekturna, Lisinopril, Spironolactone
Texas Tech University Health Sciences Center
Diastolic Heart Failure
08/09
08/09
NCT00732407: Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)

Unknown status
N/A
40
NA
aliskiren, losartan
Assaf-Harofeh Medical Center
Diabetes Mellitus, Atherosclerosis
09/09
 
NCT01454583: Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany

Completed
N/A
15337
Europe
Aliskiren, Rasilez, ACE-I/ARB, No RAS-inhibition
Stiftung Institut fuer Herzinfarktforschung, Novartis Pharmaceuticals
Arterial Hypertension
10/09
07/12
NCT00627861: Combined Renin Inhibition/Beta-blockade

Terminated
N/A
1
US
Aliskiren, Tekturna, Extended-release metoprolol, Toprol-XL
The Rogosin Institute
Hypertension
05/10
05/10
NCT01393860: Real-world Aliskiren Use in Diabetic Patients

Completed
N/A
200
US
Novartis
Diabetes, Hypertension
06/11
 
NCT00935064: The Effect of Renin Inhibition on Nerve Function in Diabetes

Completed
N/A
60
US
Aliskiren, Placebo
Christiana Care Health Services
Diabetes
10/11
04/12
NCT01093781: Aliskiren in Patients With Idiopathic Membranous Nephropathy

Withdrawn
N/A
0
US
Aliskiren, Tekturna
Mayo Clinic
Idiopathic Membranous Nephropathy
12/11
12/11
NCT01165983: The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes

Completed
N/A
124
US
Placebo, Aliskiren, Trade name: Tekturna
Beth Israel Deaconess Medical Center, Novartis Pharmaceuticals
Diabetes Type 2
01/12
 
NCT01252238: Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance

Terminated
N/A
24
US
Aliskiren, Valsartan and Aliskiren, Amlodipine
Brigham and Women's Hospital
Insulin Sensitivity, Aortic Compliance, Diastolic Function
12/12
12/12
NCT01298258: Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure

Unknown status
N/A
120
RoW
Aliskiren
Taipei Veterans General Hospital, Taiwan, National Taiwan University Hospital
Heart Failure
07/13
07/13
NCT01425242 / 2011-000538-12: Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension

Terminated
N/A
3
Europe
Aliskiren, Rasilez, Amlodipine, Norvasc
Amsterdam UMC, location VUmc, Novartis
Hypertension, Abdominal Aortic Aneurysm
12/13
12/13
NCT02446548: Influence of Aliskiren on Albuminuria After Kidney Transplantation

Completed
N/A
18
Europe
aliskiren, Rasilez (Novarits Europe), losartan, Xartan (Adamed, Poland), Placebo
Medical University of Gdansk
Albuminuria
04/14
11/14
NCT01420068 / 2011-004411-22: 52-104 Week Off-therapy Second Extension to Study CSPP100A2365

Completed
N/A
106
US, Europe, RoW
SPP100
Noden Pharma
Hypertension
08/17
08/17
ChiCTR1800017739: A study for the effect of aliskiren on endothelial progenitor cells in patients with hypertension

Recruiting
N/A
40
 
drug(aliskiren) ;Nil
The First Affiliated Hospital, Sun Yat-sen University; The First Affiliated Hospital, Sun Yat-sen University, the project of Zhu Jiang Science and Technology new star of Guangzhou City
hypertension
 
 
NCT04467931: ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Completed
N/A
22213
US
ACEI/ARB, benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, trandolapril, azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan, Non-ACEI/ARB, doxazosin, prazosin, terazosin, acebutolol, nebivolol, atenolol, betaxolol, bisoprolol, metoprolol, pindolol, penbutolol, carvedilol, labetalol, nadolol, propranolol, timolol, amlodipine, felodipine, isradipine, nifedipine, nicardipine, nisoldipine, diltiazem, verapamil, clonidine, guanfacine, guanabenz, methyldopa, reserpine, hydralazine, minoxidil, aliskiren, spironolactone, eplerenone, bumetanide, furosemide, ethacrynic acid, torsemide, amiloride, triamterene, bendroflumethiazide, chlorothiazide, chlorthalidone, hydrochlorothiazide, indapamide, metolazone, ACEI, ARB
University of Utah, VA Salt Lake City Health Care System, University of Pennsylvania, Wake Forest University Health Sciences, University of Florida, Johns Hopkins Bloomberg School of Public Health, Boston University, Northwestern University, Edith Nourse Rogers Memorial Veterans Hospital, Columbia University, MedStar Georgetown University Hospital
Hypertension, COVID
10/20
12/20
ChiCTR2000032314: A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension

Recruiting
N/A
242
 
Aliskiren with Standard Care ;Nifedipine with Standard Care
West China Hospital, Sichuan University; West China Hospital, Sichuan University, West China Hospital, Sichuan University
Novel Coronavirus Pneumonia (COVID-19)N; hypertension
 
 

Download Options